Dose intensified preoperative chemotherapy with doxorubicin/docetaxel in operable breast cancer - A phase II trial

被引：0
|
作者：
Blohmer, JU
Tulusan, AH
Jackisch, C
Kaufmann, M
Costa, SD
von Minckwitz, G
Eiermann, W
机构：
[1] Univ Frankfurt, Womens Hosp, D-6000 Frankfurt, Germany
[2] Univ Munster, Womens Hosp, D-4400 Munster, Germany
[3] Univ Bayreuth, Womens Hosp, Bayreuth, Germany
[4] Univ Bern, Womens Hosp, Berlin, Germany
[5] Rot Kreuz Krh, Munich, Germany
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
33P
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [31] Phase II trial of vinorelbine (Navelbine) - Doxorubicin combination chemotherapy in patients with advanced breast cancer
    Youssef, Amer Al Chikh
    El Shatty, Iyad
    El Shatty, Rakan
    Gasmi, Jamal
    ANNALS OF ONCOLOGY, 2004, 15 : 47 - 47
  • [32] Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer:: The GEPARDUO Study of the German Breast Group
    von Minckwitz, G
    Raab, G
    Caputo, A
    Schütte, M
    Hilfrich, F
    Blohmer, JU
    Gerber, B
    Costa, SD
    Merkle, E
    Eidtmann, H
    Lampe, D
    Jackisch, C
    du Bois, A
    Kaufmann, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) : 2676 - 2685
  • [33] Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer
    Guarneri, Valentina
    Frassoldati, Antonio
    Ficarra, Guido
    Puglisi, Fabio
    Andreetta, Claudia
    Michelotti, Andrea
    Cresti, Nicola
    Boni, Corrado
    Bisagni, Giancarlo
    Berardi, Rossana
    Battelli, Nicola
    Santoro, Armando
    Banna, Giuseppe
    Bottini, Alberto
    Di Blasio, Beatrice
    Maiorana, Antonino
    Piacentini, Federico
    Giovannelli, Simona
    Jovic, Gordana
    Conte, PierFranco
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 110 (01) : 127 - 134
  • [34] Phase I trial of pegylated liposomal doxorubicin and docetaxel in advanced breast cancer
    Sparano, JA
    Malik, U
    Rajdev, L
    Sarta, C
    Hopkins, U
    Wolff, AC
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (12) : 3117 - 3125
  • [35] Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer
    Valentina Guarneri
    Antonio Frassoldati
    Guido Ficarra
    Fabio Puglisi
    Claudia Andreetta
    Andrea Michelotti
    Nicola Cresti
    Corrado Boni
    Giancarlo Bisagni
    Rossana Berardi
    Nicola Battelli
    Armando Santoro
    Giuseppe Banna
    Alberto Bottini
    Beatrice Di Blasio
    Antonino Maiorana
    Federico Piacentini
    Simona Giovannelli
    Gordana Jovic
    PierFranco Conte
    Breast Cancer Research and Treatment, 2008, 110 : 127 - 134
  • [36] Is ERBB-2 A predictive marker for response to primary chemotherapy for operable breast cancer:: A prospective study in a phase ii randomized trial of doxorubicin/cyclophosphamide (AC) and doxorubicin/paclitaxel (AT)
    De Crémoux, P
    Diéras, V
    Le Doussal, V
    Vincent-Salomon, A
    Tubiana-Hulin, M
    Pierga, JY
    Spyratos, F
    Magdelénat, H
    Pouillart, P
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S86 - S86
  • [37] Preoperative doxorubicin/cyclophosphamide followed by docetaxel (AC-Doc) versus dose-dense doxorubicin and docetaxel (Adoc) as preoperative treatment in operable breast cancer: first analysis of the event-free survival of the GeparDuo-Study.
    Raab, G
    Kaufmann, M
    Schuette, M
    Hilfrich, J
    Blohmer, JU
    Gerber, B
    Costa, SD
    Eidtmann, H
    Eiermann, W
    Lampe, D
    Jackisch, C
    du Bois, A
    von Minckwitz, G
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S222 - S222
  • [38] Primary chemotherapy with sequential docetaxel followed by docetaxel and epirubicin in large operable breast cancer
    Frutuoso, C.
    Henriques, I.
    Pazos, I.
    Abraul, E.
    Pego, A.
    Belo, J.
    Campos, O.
    Gervasio, H.
    De Oliveira, C.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2007, 28 (06) : 447 - 450
  • [39] A randomized phase II trial comparing preoperative plus perioperative chemotherapy with preoperative chemotherapy in patients with locally advanced breast cancer
    Rocca, Andrea
    Peruzzotti, Giulia
    Ghisini, Raffaella
    Viale, Giuseppe
    Veronesi, Paolo
    Luini, Alberto
    Intra, Mattia
    Pietri, Elisabetta
    Curigliano, Giuseppe
    Giovanardi, Filippo
    Maisonneuve, Patrick
    Goldhirsch, Aron
    Colleoni, Marco
    ANTI-CANCER DRUGS, 2006, 17 (10) : 1201 - 1209
  • [40] Phase II randomized trial of docetaxel (D) monotherapy vs epirubicin plus docetaxel (ED) as neoadjuvant treatment of operable breast cancer (BC).
    Bougnoux, P
    Combe, M
    Goudier, MJ
    Facchini, T
    Lotz, V
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 27S - 27S
12345